This Bioforum will provide the latest insights on delivering increased speed, greater flexibility and enhanced quality while reducing the cost, and risks of navigating the evolving biopharma landscape
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Merck’s first microbiology application and training lab in India
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
TPE tubing from Freudenberg also offers many different sterilization options including autoclave, gamma irradiation, x-ray, and e-beam
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Support for biologics manufacturability and Industry 4.0 initiatives
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Subscribe To Our Newsletter & Stay Updated
